Interactions with Dietary Supplements
Biotin
Several controlled studies have shown that long-term anticonvulsant treatment decreases blood
levels of biotin.1 2 3 4 In children, a deficiency
of biotin can lead to withdrawn behavior and a delay in mental development. Adults with low
biotin levels might experience a loss of appetite, feelings of discomfort or uneasiness,
mental depression, or hallucinations. To avoid side
effects, individuals taking anticonvulsants should supplement with biotin either alone or as
part of a multivitamin.
Calcium
Individuals on long-term multiple anticonvulsant therapy may develop below-normal blood levels
of calcium, which may be related to drug-induced vitamin D
deficiency.5 Two infants born to women taking high doses of phenytoin and phenobarbital while pregnant developed jitteriness and tetany
(a syndrome characterized by muscle twitches) cramps, and spasm during the first two weeks of
life.6 Controlled research is needed to determine whether pregnant women who are taking anticonvulsant medications should
supplement with additional amounts of calcium and vitamin D.
L-Carnitine
Several controlled and preliminary studies showed that multiple drug therapy for seizures results in dramatic reductions in blood carnitine
levels.7 8 9 Further controlled research is needed to
determine whether children taking anticonvulsants might benefit by supplementing with
L-carnitine, since current studies yield conflicting results. For example, one controlled
study indicated that children taking valproic acid and
carbamazepine received no benefit from supplementing with L-carnitine.10 However,
another small study revealed that children taking valproic acid experienced less fatigue and
excessive sleepiness following L-carnitine supplementation.11 Despite the lack of
well-controlled studies, individuals who are taking anticonvulsants and experiencing side
effects might benefit from supplementing with L-carnitine.
Folic acid
Several studies have shown that multiple anticonvulsant therapy reduces blood levels of folic
acid and dramatically increases homocysteine
levels.12 13 14 Homocysteine, a potential marker for folic
acid deficiency, is a compound used experimentally to induce seizures and is associated with
atherosclerosis.
One preliminary study showed that pregnant women who
use anticonvulsant drugs without folic acid supplementation have an increased risk of having a
child with birth defects, such as heart defects,
cleft lip and palate, neural tube defects, and skeletal abnormalities. However,
supplementation with folic acid greatly reduces the risk.15 Consequently, some
healthcare practitioners recommend that women taking multiple anticonvulsant drugs supplement
with 5 mg of folic acid daily, for three months prior to conception and during the first
trimester, to prevent folic acid deficiency-induced birth defects.16 Other
practitioners suggest that 1mg or less of folic acid each day is sufficient to prevent
deficiency during pregnancy.17
One well-controlled study showed that adding folic acid to multiple anticonvulsant therapy
resulted in reduced seizure frequency.18 In addition, three infants with seizures
who were unresponsive to medication experienced immediate relief following supplementation
with the active form of folic acid.19
Despite the apparent beneficial effects, some studies have indicated that as little as 0.8
mg of folic acid taken daily can increase the frequency and/or severity of
seizures.20 21 22 23 However, a recent controlled
study showed that both healthy and epileptic women taking less than 1 mg of folic acid per day
had no increased risk for seizures.24 Until more is known about the risks and
benefits of folic acid, individuals taking multiple anticonvulsant drugs should consult with
their healthcare practitioner before supplementing with folic acid. In addition, pregnant
women or women who might become pregnant while taking anticonvulsant drugs should discuss
folic acid supplementation with their practitioner.
Vitamin A
Anticonvulsant drugs can occasionally cause birth
defects when taken by pregnant women, and their
toxicity might be related to low blood levels of vitamin A. One controlled study showed that
taking multiple anticonvulsant drugs results in dramatic changes in the way the body utilizes
vitamin A.25 Further controlled research is needed to determine whether
supplemental vitamin A might prevent birth defects in children born to women on multiple
anticonvulsant therapy. Other research suggests that ingestion of large amounts of vitamin A
may promote the development of birth defects, although the studies are conflicting.
Vitamin B6
One controlled study revealed that taking anticonvulsant drugs dramatically reduces blood
levels of vitamin B6.26 A nutritional deficiency of vitamin B6 can lead to an
increase in homocysteine blood levels, which
has been associated with atherosclerosis. Vitamin
B6 deficiency is also associated with symptoms such as dizziness, fatigue, mental depression, and seizures. On the other hand, supplementation
with large amounts of vitamin B6 (80–200 mg per day) has been reported to reduce blood
levels of some anticonvulsant drugs, which could theoretically trigger seizures. People taking
multiple anticonvulsant drugs should discuss with their doctor whether supplementing with
vitamin B6 is advisable.
Vitamin B12
Anemia is an uncommon side effect experienced by people taking anticonvulsant drugs. Though
many researches believe that low blood levels of folic
acid are involved, the effects might be caused by a vitamin B12 deficiency. Deficiencies
of folic acid and vitamin B12 can lead to nerve and mental problems. One study revealed that
individuals on long-term anticonvulsant therapy, despite having no laboratory signs of anemia,
had dramatically lower levels of vitamin B12 in their cerebrospinal fluid (the fluid that
bathes the brain) when compared with people who were not taking seizure medications.
Improvement in mental status and nerve function was observed in a majority of symptomatic
individuals after taking 30 mcg of vitamin B12 daily for a few days.27 Another
study found that long-term anticonvulsant therapy had no effect on blood levels of vitamin
B12.28 The results of these two studies indicate that people taking anticonvulsant
drugs might experience side effects of vitamin B12 deficiency, and that the deficiency is not
easily detected by the usual blood tests. Therefore, individuals taking anticonvulsant drugs
for several months or years might prevent nerve and mental problems by supplementing with
vitamin B12.
Vitamin D
Though research results vary, long-term use of anticonvulsant drugs appears to interfere with
vitamin D activity, which might lead to softening of bones (osteomalacia). One study showed that blood levels of vitamin D in
males taking anticonvulsants were lower than those found in men who were not taking seizure
medication.29 In a controlled study, bone strength improved in children taking
anticonvulsant drugs who were supplemented with the activated form of vitamin D and 500 mg per
day of calcium for nine months.30 Some research
suggests that differences in exposure to sunlight—which normally increases blood levels
of vitamin D—might explain why some studies have failed to find a beneficial effect of
vitamin D supplementation. In one controlled study, blood vitamin D levels in children taking
anticonvulsants were dramatically lower in winter months than in summer months.31
Another study of 450 people in Florida taking anticonvulsants found that few had drug-induced
bone disease.32 Consequently, people taking anticonvulsant drugs who do not receive
adequate sunlight should supplement with 400 IU of vitamin D each day to help prevent
osteomalacia.
Vitamin E
Two studies showed that individuals taking phenytoin and
phenobarbital had lower blood vitamin E levels than those who received no treatment for
seizures.33 34 Though the consequences of lower blood levels of vitamin
E are unknown, people taking multiple anticonvulsant drugs should probably supplement with 100
to 200 IU of vitamin E daily to prevent a deficiency.
Vitamin K
Some studies have shown that babies born to women taking anticonvulsant drugs have low blood
levels of vitamin K, which might cause bleeding in the infant.35 Though some
researchers recommend vitamin K supplementation prior to delivery,36 37
not all agree that supplementation for women taking anticonvulsant drugs is
necessary.38 Until more information is available, pregnant women or women who might become pregnant while taking
anticonvulsant drugs should discuss vitamin K supplementation with their healthcare
practitioner.
References:
1. Mock DM, Dyken ME. Biotin catabolism is accelerated in adults
receiving long-term therapy with anticonvulsants. Neurology 1997;49:1444–7.
2. Mock DM, Mock NI, Nelson RP, Lombard KA. Disturbances in biotin
metabolism in children undergoing long-term anticonvulsant therapy. J Pediatr
Gastroenterol Nutr 1998;26:245–50.
3. Krause KH, Bonjour JP, Berlit P, Kochen W. Biotin status of
epileptics. Ann NY Acad Sci 1985;447:297–313.
4. Krause KH, Bonjour JP, Berlit P, et al. Effect of long-term treatment
with antiepileptic drugs on the vitamin status. Drug Nutr Interact
1988;5:317–43.
5. Bouillon R, Reynaert J, Claes JH, et al. The effect of anticonvulsant
therapy on serum levels of 25-hydroxy-vitamin D, calcium, and parathyroid hormone. J Clin
Endocrinol Metab 1975;41:1130–5.
6. Friis B, Sardemann H. Neonatal hypocalcaemia after intrauterine
exposure to anticonvulsant drugs. Arch Dis Child 1977;52:239–41.
7. Hiraoka A, Arato T, Tominaga I. Reduction in blood free carnitine
levels in association with changes in sodium valproate (VPA) disposition in epileptic patients
treated with VPA and other anti-epileptic drugs. Biol Pharm Bull
1997;20:91–3.
8. Morita J, Yuge K, Yoshino M. Hypocarnitinemia in the handicapped
individuals who receive a polypharmacy of antiepileptic drugs. Neuropediatrics
1986;17:203–5.
9. Hug G, McGraw CA, Bates SR, Landrigan EA. Reduction of serum carnitine
concentrations during anticonvulsant therapy with phenobarbitol, valproic acid, phenytoin and
carbamazepine in children. J Pedr 1991;119:799–802.
10. Freeman JM, Vining EPG, Cost S, Singhi P. Does carnitine
administration improve the symptoms attributed to anticonvulsant medications?: A
double-blinded, crossover study. Pediatrics 1994;93:893–5.
11. Van Wouwe JP. Carnitine deficiency during valproic acid treatment.
Int J Vitam Nutr Res 1995;65:211–4.
12. Hendel J, Dam M, Gram L, et al. The effects of carbamazepine and
valproate on folate metabolism in man. Acta Neurol Scand 1984;69:226–31.
13. Apeland T, Mansoor MA, Strandjord RE, Kristensen O. Homocysteine
concentrations and methionine loading in patients on antiepileptic drugs. Acta Neurol
Scand 2000;101:217–23.
14. Schwaninger M, Ringleb P, Winter R, et al. Elevated plasma
concentrations of homocysteine in antiepileptic drug treatment. Epilepsia
1999;40:345–50.
15. Biale Y, Lewenthal H. Effect of folic acid supplementation on
congenital malformations due to anticonvulsive drugs. Eur J Obstet Gynecol Reprod
Biol 1984;18:211–6.
16. Nulman I, Laslo D, Koren G. Treatment of epilepsy in pregnancy.
Drugs 1999;57:535–44 [review].
17. Hiilesmaa VK, Teramo K, Granstrom JL, et al. Serum folate
concentrations during pregnancy in women with epilepsy: relation to antiepileptic drug
concentrations, number of seizures, and fetal outcome. Br Med J (Clin Res Ed)
1983;287:577–9.
18. Gibberd FB, Nicholls A, Wright MG. The influence of folic acid on the
frequency of epileptic attacks. Eur J Clin Pharmacol 1981;19:57–60.
19. Torres OA, Miller VS, Buist NM, Hyland K. Folinic acid-responsive
neonatal seizures. J Child Neurol 1999;14:529–32.
20. Guidolin L, Vignoli A, Canger R. Worsening in seizure frequency and
severity in relation to folic acid administration. Eur J Neurol
1998;5:301–3.
21. Lewis DP, Van Dyke DC, Willhite LA. Phenytoin-folic acid interaction.
Ann Pharmacother 1995;29:726–35 [review].
22. Berg MJ, Rivey MP, Vern BA, et al. Phenytoin and folic acid:
individualized drug-drug interaction. Ther Drug Monit 1983;5:395–9.
23. Reynolds EH. Effects of folic acid on the mental state and fit
frequency of drug treated epileptic patients. Lancet 1967;1:1086.
24. Eros E, Geher P, Gomor B, Czeizel AE. Epileptogenic activity of folic
acid after drug induces SLE (folic acid and epilepsy). Eur J Obstet Gynecol Reprod
Biol 1998;80:75–8.
25. Nau H, Tzimas G, Mondry M, et al. Antiepileptic drugs alter
endogenous retinoid concentrations: a possible mechanism of teratogensis of anticonvulsant
therapy. Life Sci 1995;57:53–60.
26. Schwaninger M, Ringleb P, Winter R, et al. Elevated plasma
concentrations of homocysteine in antiepileptic drug treatment. Epilepsia
1999;40:345–50.
27. Frenkel EP, McCall MS, Sheehan RG. Cerebrospinal fluid folate, and
vitamin B12 in anticonvulsant-induced megaloblastosis. J Lab Clin Med
1973;81:105–15.
28. Schwaninger M, Ringleb P, Winter R, et al. Elevated plasma
concentrations of homocysteine in antiepileptic drug treatment. Epilepsia
1999;40:345–50.
29. Telci A, Cakatay U, Kurt BB, et al. Changes in bone turnover and
deoxypyridinoline levels in epileptic patients Clin Chem Lab Med 2000
38:47–50.
30. Jekovec-Vrhovsek M, Kocijancic A, Prezelj J. Effect of vitamin D and
calcium on bone mineral density in children with CP and epilepsy in full-time care. Dev
Med Child Neurol 2000;42:403–5.
31. Riancho JA, Del Arco C, Arteaga R, et al. Influence of solar
irradiation on vitamin D levels in children on anticonvulsant drugs. Acta Neurol
Scand 1989;79:296–9.
32. Williams C, Netzloff M, Folkerts L, et al. Vitamin D metabolism and
anticonvulsant therapy: effect of sunshine on incidence of osteomalacia. South Med J
1984;77:834.
33. Higashi A, Tamari H, Ikeda T, et al. Serum vitamin E concentration in
patients with severe multiple handicaps treated with anticonvulsants. Pediatr Pharmacol
(New York) 1980;1:129–34.
34. Higashi A, Ikeda T, Matsukura M, Matsuda I. Serum zinc and vitamin E
concentrations in handicapped children treated with anticonvulsants. Dev Pharmacol
Ther 1982;5:109–13.
35. Cornelissen M, Steegers-Theunissen R, Kollee L, et al. Increased
incidence of neonatal vitamin K deficiency resulting from maternal anticonvulsant therapy.
Am J Obstet Gynecol 1993;168:923–8.
36. Nulman I, Laslo D, Koren G. Treatment of epilepsy in pregnancy.
Drugs 1999;57:535–44 [review].
37. Cornelissen M, Steegers-Theunissen R, Kollee L, et al.
Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents
neonatal vitamin K deficiency. Am J Obstet Gynecol 1993;168:884–8.
38. Hey E. Effect of maternal anticonvulsant treatment on neonatal blood
coagulation. Arch Dis Child Fetal Neonatal Ed 1999;81:F208–10.
39. Threlkeld DS, ed. Central Nervous System Drugs, Anticonvulsants,
Miscellaneous, Gabapentin. In Facts and Comparisons Drug Information. St. Louis, MO:
Facts and Comparisons, Nov 1993, 284t–4xa.